Medical Reserch and Education ›› 2018, Vol. 35 ›› Issue (4): 1-5.DOI: 10.3969/j.issn.1674-490X.2018.04.001
Received:2018-05-06
Online:2018-08-25
Published:2018-08-25
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: //yxyjyjy.hbu.edu.cn/EN/10.3969/j.issn.1674-490X.2018.04.001
| [1] 吴海星, 侯晓节, 徐希妮, 等. 五味子乙素抗肿瘤的多种作用机制[J]. 吉林医药学院学报, 2012, 33(2): 107-110. [2] 李贺, 李宁, 刘聪, 等. 五味子乙素对ICR小鼠的抗焦虑作用及其作用机制[J]. 吉林大学学报(医学版), 2018, 44(1): 78-82. [3] JIANG E P, LI H, YU C R, et al. Schisandrin B protects PC12 cells against oxidative stress of neurodegenerative diseases[J]. Neuroreport, 2015, 26(6): 360-366. [4] KIM S R, LEE M K, KOO K A, et al. Dibenzocyclooctadiene lignans from Schisandra chinensis protect primary cultures of rat cortical cells from glutamate-induced toxicity[J]. J Neurosci Res, 2010, 76(3): 397-405. [5] 商红军, 孟宪军, 李斌, 等. 北五味子乙素体外抗氧化及抑菌作用的研究[J]. 食品工业科技, 2012, 33(2): 170-172. [6] PHILIP Y L, KAM M K. Schisandrin B as a Hormetic Agent for Preventing Age-Related Neurodegenerative Diseases[J]. Oxid Med Cell Longev, 2012, 2012(3): 25082. [7] 王飞, 徐兆发, 冯雪英, 等. 沙棘油和五味子乙素染毒对镉致大鼠肾损伤的影响[J]. 环境与健康杂志, 2008, 25(11): 970-972. [8] IP S P, KO K M. The crucial antioxidant action of Schisandrin B in protecting against carbon tetrachloride hepatotoxicity in mice: a comparative study with butylated hydroxytoluene[J]. Biochem Pharmacol, 1996, 52(11): 1687-1693. [9] CHIU R Y, LEUNG H Y, KO K M. SchB enhances renal mitochon-drial antioxidant status, functional and structural integrity, and protects against gentamicin induced nephrotoxicity in rats[J]. Biol Pharm Bull, 2008, 31(4): 602-605. [10] 刘巍, 徐兆发, 杨海波,等. 五味子乙素对汞性大鼠急性肾损伤的影响[J]. 中国工业医学杂志, 2011, 24(2): 89-91. [11] 原丽欣. 五味子乙素对顺铂所致大鼠肾氧化损伤的保护作用[J]. 中国医院药学杂志, 2014, 34(10): 825-828. [12] WANG L, NISHIDA H, OGAWA Y, et al. Prevention of oxidative injury in PC12 cells by a traditional Chinese medicine, Shengmai San as a modelof an tioxidant-based composite formula[J]. Biol Pharm Bull, 2003, 26(7): 1000-1004. [13] 杨擎, 李娜, 隋欣, 等. 五味子乙素靶向调节Aβ及下游NF-κB/TNF-α信号通路保护受损神经元的分子机制[J]. 中华中医药杂志, 2017,32(5): 2064-2069. [14] 曾雯琼, 徐青, 许银燕. 五味子乙素对人卵巢癌Skov3细胞株的增殖、凋亡及Wnt/β-catenin信号通路的影响[J]. 临床肿瘤学杂志, 2014, 19(7): 589-593. [15] 姜恩平, 李贺, 于春艳. 五味子乙素通过p38MAPK信号通路对结肠癌SW480细胞凋亡和侵袭的影响[J]. 吉林大学学报(医学版), 2015, 4(41):675-679. [16] 李梅, 金晶, 李佳, 等. 五味子乙素激活Nrf2/ARE通路对顺铂致HK-2细胞氧化应激损伤的保护作用[J]. 药学学报, 2012, 47(11): 1434-1439. [17] 孙红霞, 陈建光. 北五味子乙素对大鼠离体心肌缺血再灌注损伤的保护作用及分子机制[J]. 食品科学, 2016, 37(15): 237-241. [18] 杨擎, 隋欣, 王宝森, 等. 五味子乙素对谷氨酸诱导SH-SY5Y细胞损伤的保护作用及其机制[J]. 吉林大学学报(医学版), 2016, 42(1):80-84. [19] XIN D Q, HU Z M,HUO H J, et al. Schisandrin B attenuates the inflammatory response, oxidative stress and apoptosis induced by traumatic spinal cord injury via inhibition of p53 signaling in adult rats[J]. Mol Med Rep, 2017, 16(1): 533-538. [20] 魏菲, 刘斌, 肖娜, 等. 五味子乙素减轻博莱霉素诱导的肺纤维化[J]. 天津中医药大学学报, 2017, 36(3):200-204. [21] 郑海洲, 张杰, 肖程程, 等. 五味子乙素抗肾纤维化作用及机制研究[J]. 中国现代医学杂志, 2017, 27(27):1-6. [22] 章艳燕, 侯海燕, 陈晓, 等. 五味子乙素对BaP致HTR8-SVneo细胞DNA氧化损伤的保护作用[J]. 辽宁中医杂志, 2015, 42(11): 2172-2175. [23] GIRIDHARAN V V, THANDAVARAYAN R A, ARUMUGAM S, et al. Schisandrin B Ameliorates ICV-Infused AmyloidβInduced Oxidative Stress and Neuronal Dysfunction through Inhibiting RAGE/NF-κB/MAPK and Up-Regulating HSP/Beclin Expression[J]. PLoS One, 2015, 10(11): e0142483. [24] ABDUL H M, BUTTERFIELD D A. Involvement of PI3K/PKG/ERK1/2 signaling pathways in cortical neurons to trigger protection by cotreatment of acetyl-L-carnitine and alpha-lipoic acid against HNE-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease[J]. Free Radic Biol Med, 2007, 42(3): 371-384. [25] ICHIKAWA H, WANG L, KONISHI T. Prevention of cerebral oxidative injury by post-ischemic intravenous administration of Shengmai San[J]. Am J Chin Med, 2006, 34(4): 591-600. [26] CHEN N, CHIU P Y, KO K M. Schisandrin Benhance cerebral mitochondrial antioxidant status and structural integrity, and protedts against cerebral ischiemia reperlusion injury in rats[J]. Biol Pharm Bull, 2008, 31(7): 1387-1391. [27] CHIU P Y, MAK D H, POON M K, et al. Role of cytochromeP-450 in schisandrin B-induced antioxidant and heatshock responses in mouse liver[J]. Life Sci, 2005, 77(23): 2887-2895. [28] KIM J S, HE L J. Mitochondrial permeability transition: a common pathway to necrosis and apoptosis[J].Biochem Bioph Res Co, 2003, 304(3): 463-470. [29] JEMMERSON R, DUBINSKY J M, BRUSTOVETSKY N. Cytochrome c release from CNS mitochondria and potential for clinical intervention in apoptosis-mediated CNS diseases[J].Antioxid Redox Sign, 2005, 7(7): 1158-1172. [30] TREMELLEN K. Oxidative stress and male infertility-a clinical perspective[J]. Hum Reprod Update, 2008, 14(3): 243-258. [31] 刘建国, 赵红乐, 金保方. 氧化应激与男性不育研究进展[J]. 中华中医药学刊, 2016, 34(9): 2104-2106. [32] 杨洋, 梁毓, 李颖, 等. 精子DNA碎片化率对男性不育影响的研究[J]. 中国优生与遗传杂志, 2016, 24(7): 110-111. [33] 蔡文伟, 莫敦胜, 江 楠, 等. 男性不育患者精子 DNA 完整性与精浆氧化应激水平的关系及其对体外受精的影响[J]. 中华男科学杂志, 2016, 22(10): 892-896. [34] LOU S M, SUN Q Y. Autophagy Is Not Involved in the Degradation of Sperm Mitochondria after Fertilization in Mice[J]. Autophagy, 2013, 9(12):2156. [35] 石明华. 活性氧与男性不育相关性的研究进展[J]. 中国临床新医学, 2013, 6(5): 487-491. [36] 刘 丽, 王美姣, 于廷和, 等. 线粒体靶向抗氧化剂 Mitoquinone 对人精子冻融氧化应激损伤的保护作用[J]. 中华男科学杂志, 2016, 22(3): 205-211. [37] 郭颖. 精子氧化损伤及抗氧化剂的研究[J]. 国际生殖健康/计划生育杂志, 2012, 31(6): 475-478. [38] 何锦, 刘琦, 苏泽智, 等. SchB对猪精液常温保存效果的影响[J]. 中国畜牧杂志, 2015, 51(15): 24-27. [39] 高秀霞, 陈娟, 刘传丽, 等. 五味子乙素对苯并芘致不育模型小鼠精液质量的影响[J].新乡医学院学报, 2015, 32(12): 1073-1077. |
| [1] | . [J]. Journal of Hebei Medical College for Continuing Education, 2023, 40(3): 1-7. |
| [2] | JIANG Le,WANG Xiaobing,HE Ershu,ZHENG Xiaoye,GONG Zhiting. Effect of RG108 on proliferation and gene expression of HT22 cell line [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(4): 1-7. |
| [3] | LUO Fameng, LIU Rong, ZHANG Haiyan. Advances on drug management in patients with inflammatory bowel disease [J]. Journal of Hebei Medical College for Continuing Education, 2022, 39(2): 66-71. |
| [4] | . [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(4): 1-7. |
| [5] | . [J]. Journal of Hebei Medical College for Continuing Education, 2021, 38(2): 1-7. |
| [6] | . [J]. Journal of Hebei Medical College for Continuing Education, 2020, 37(6): 14-22. |
| [7] | . [J]. Journal of Hebei Medical College for Continuing Education, 2020, 37(5): 1-13. |
| [8] | . [J]. Medical Reserch and Education, 2020, 37(1): 14-20. |
| [9] | . [J]. Medical Reserch and Education, 2019, 36(6): 21-27. |
| [10] | . [J]. Medical Reserch and Education, 2019, 36(4): 1-4. |
| [11] | . [J]. Medical Reserch and Education, 2019, 36(3): 15-18. |
| [12] | . [J]. Medical Reserch and Education, 2019, 36(1): 1-5. |
| [13] | . [J]. Medical Reserch and Education, 2018, 35(6): 10-18. |
| [14] | . [J]. Medical Reserch and Education, 2018, 35(6): 19-23. |
| [15] | . [J]. Medical Reserch and Education, 2018, 35(6): 24-29. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
